Could a low-dose drug boost blood health in rare platelet disorder?

This study tests whether low-dose sirolimus can safely improve blood cell function in adults with RUNX1 familial platelet disorder, a genetic condition that raises bleeding and leukemia risks. Six participants receive the drug and are monitored for side effects and changes in blood counts. The goal is to see if this approach can help manage the disease, not cure it.